COOPER JOHN G 4

4 · ROCKWELL MEDICAL, INC. · Filed Jul 6, 2026

AI-generated summary of this filing

Updated Jul 6, 2026

Rockwell Medical Director John G. Cooper Receives RSU Award

What Happened

John G. Cooper, a director of Rockwell Medical, received a grant (transaction code A) of 9,633 restricted stock units (RSUs) on July 1, 2026. The grant is shown at $0.00 per share (no cash paid at grant). The RSUs vest on July 1, 2027, subject to Cooper’s continued service through the 2027 Annual Meeting.

Key Details

Transaction date: 2026-07-01; Form 4 filed: 2026-07-06.
Shares granted: 9,633 RSUs; reported price: $0.00 per share.
Vesting condition: July 1, 2027, contingent on continued service through the 2027 Annual Meeting (footnote F1).
Reverse split note: A 1-for-10 reverse split took effect 12:01 AM on July 1, 2026; outstanding awards and reported share counts were proportionally adjusted (footnote F2).
Shares owned after transaction: not specified in the provided excerpt (the filing indicates adjusted holdings post-reverse split).
Filing timeliness: the filing date (July 6) is shown for the July 1 transaction; the excerpt does not explicitly flag a late filing.

Context

RSU grants are common director compensation and do not reflect an immediate market purchase or sale. They only convert to shares (and potentially become sells) if/when they vest and are delivered. The reverse split reduced reported share counts and adjusted awards proportionally — review the company’s SEC filings for pre-split figures or further detail.

Form 4

Period: 2026-07-01

Director

Transactions

Footnotes (2)

[F1]Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
[F2]Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Signature

/s/ Megan Timmins, Attorney-in-Fact for John G. Cooper|2026-07-06

1 file